[1]
C. Tian, “Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma”, Radiol Oncol, vol. 55, no. 1, pp. 66–76, Feb. 2021.